499 related articles for article (PubMed ID: 29381513)
1. A Systematic Review of Outcomes Associated With Withholding or Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Before Noncardiac Surgery.
Hollmann C; Fernandes NL; Biccard BM
Anesth Analg; 2018 Sep; 127(3):678-687. PubMed ID: 29381513
[TBL] [Abstract][Full Text] [Related]
2. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery.
Kheterpal S; Khodaparast O; Shanks A; O'Reilly M; Tremper KK
J Cardiothorac Vasc Anesth; 2008 Apr; 22(2):180-6. PubMed ID: 18375317
[TBL] [Abstract][Full Text] [Related]
3. Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery: An Analysis of the Vascular events In noncardiac Surgery patIents cOhort evaluatioN Prospective Cohort.
Roshanov PS; Rochwerg B; Patel A; Salehian O; Duceppe E; Belley-Côté EP; Guyatt GH; Sessler DI; Le Manach Y; Borges FK; Tandon V; Worster A; Thompson A; Koshy M; Devereaux B; Spencer FA; Sanders RD; Sloan EN; Morley EE; Paul J; Raymer KE; Punthakee Z; Devereaux PJ
Anesthesiology; 2017 Jan; 126(1):16-27. PubMed ID: 27775997
[TBL] [Abstract][Full Text] [Related]
4. Renin-angiotensin-aldosterone-system inhibition is safe in the preoperative period surrounding carotid endarterectomy.
Steely AM; Callas PW; Bertges DJ;
J Vasc Surg; 2016 Mar; 63(3):715-21. PubMed ID: 26603543
[TBL] [Abstract][Full Text] [Related]
5. Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults.
Zou Z; Yuan HB; Yang B; Xu F; Chen XY; Liu GJ; Shi XY
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD009210. PubMed ID: 26816003
[TBL] [Abstract][Full Text] [Related]
6. Continuation of Angiotensin-Converting Enzyme Inhibitors on the Day of Surgery Is Not Associated With Increased Risk of Hypotension Upon Induction of General Anesthesia in Elective Noncardiac Surgeries.
Yoon U; Setren A; Chen A; Nguyen T; Torjman M; Kennedy T
J Cardiothorac Vasc Anesth; 2021 Feb; 35(2):508-513. PubMed ID: 32029371
[TBL] [Abstract][Full Text] [Related]
7. Perioperative management of patients treated with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: a quality improvement audit.
Vijay A; Grover A; Coulson TG; Myles PS
Anaesth Intensive Care; 2016 May; 44(3):346-52. PubMed ID: 27246933
[TBL] [Abstract][Full Text] [Related]
8. The effect of continuing versus withholding angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers on mortality and major adverse cardiovascular events in hypertensive patients undergoing elective non-cardiac surgery: study protocol for a multi-centric open-label randomised controlled trial.
Misra S; Parida S; Sahajanandan R; Behera BK; Senthilnathan M; Mariappan R; Chandy TT;
Trials; 2022 Aug; 23(1):670. PubMed ID: 35978368
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
10. Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation.
Coleman CI; Makanji S; Kluger J; White CM
Ann Pharmacother; 2007 Mar; 41(3):433-7. PubMed ID: 17341525
[TBL] [Abstract][Full Text] [Related]
11. Consequences of continuing renin angiotensin aldosterone system antagonists in the preoperative period: a systematic review and meta-analysis.
Ling Q; Gu Y; Chen J; Chen Y; Shi Y; Zhao G; Zhu Q
BMC Anesthesiol; 2018 Feb; 18(1):26. PubMed ID: 29482507
[TBL] [Abstract][Full Text] [Related]
12. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
Blessberger H; Kammler J; Domanovits H; Schlager O; Wildner B; Azar D; Schillinger M; Wiesbauer F; Steinwender C
Cochrane Database Syst Rev; 2014 Sep; (9):CD004476. PubMed ID: 25233038
[TBL] [Abstract][Full Text] [Related]
13. Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials.
Lakhdar R; Al-Mallah MH; Lanfear DE
J Card Fail; 2008 Apr; 14(3):181-8. PubMed ID: 18381180
[TBL] [Abstract][Full Text] [Related]
14. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease.
Baker WL; Coleman CI; Kluger J; Reinhart KM; Talati R; Quercia R; Phung OJ; White CM
Ann Intern Med; 2009 Dec; 151(12):861-71. PubMed ID: 20008762
[TBL] [Abstract][Full Text] [Related]
15. The risk of hypertension after preoperative discontinuation of angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists in ambulatory and same-day admission patients.
Twersky RS; Goel V; Narayan P; Weedon J
Anesth Analg; 2014 May; 118(5):938-44. PubMed ID: 24681657
[TBL] [Abstract][Full Text] [Related]
16. Effect of preoperative angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker use on hemodynamic variables in pediatric patients undergoing cardiopulmonary bypass.
Ajuba-Iwuji CC; Puttreddy S; Maxwell BG; Bembea M; Vricella L; Heitmiller E
World J Pediatr Congenit Heart Surg; 2014 Oct; 5(4):515-21. PubMed ID: 25324247
[TBL] [Abstract][Full Text] [Related]
17. Effect of continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers on the day of surgery on myocardial injury after non-cardiac surgery: A retrospective cohort study.
Kim J; Lee S; Choi J; Ryu DK; Woo S; Park M
J Clin Anesth; 2024 Jun; 94():111401. PubMed ID: 38330844
[TBL] [Abstract][Full Text] [Related]
18. Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis.
Khan MS; Fonarow GC; Ahmed A; Greene SJ; Vaduganathan M; Khan H; Marti C; Gheorghiade M; Butler J
Circ Heart Fail; 2017 Aug; 10(8):. PubMed ID: 28790052
[TBL] [Abstract][Full Text] [Related]
19. Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period.
Rosenman DJ; McDonald FS; Ebbert JO; Erwin PJ; LaBella M; Montori VM
J Hosp Med; 2008 Jul; 3(4):319-25. PubMed ID: 18698608
[TBL] [Abstract][Full Text] [Related]
20. Summary of AHRQ's comparative effectiveness review of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers added to standard medical therapy for treating stable ischemic heart disease.
White CM; Greene L
J Manag Care Pharm; 2011 Jun; 17(5 Suppl):S1-15. PubMed ID: 21780334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
